Home

STUART L MERKADEAU

CIK 1256951 · General Counsel · last filed 2022-02-23

STUART L MERKADEAU is a General Counsel who has filed 56 SEC Form 4 insider transactions across 2 companies since 2007. The most recent filing shows the insider had shares withheld for taxes covering $899 of BLI on Feb 23, 2022. Across all open-market trades the lifetime net is −$5.5M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $8.6M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$8.64M

Companies

2

Total Filings

56

Lifetime Open-Market Net

-$5.47M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Bruker Cellular Analysis, Inc. (BLI) Delisted General Counsel 159,769 $1.20 $191.7K -$3.34M 11 2022-02-23
FORM SR VP GENERAL COUNSEL 81,812 $105.57 $8.64M -$2.12M 45 2015-05-08

Recent Filings

56 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2022-02-23 Bruker Cellular Analysis, Inc. (BLI) Delisted Tax (F) −131 -$899 EDGAR
2021-11-24 Bruker Cellular Analysis, Inc. (BLI) Delisted Tax (F) −162 -$3.8K EDGAR
2021-08-24 Bruker Cellular Analysis, Inc. (BLI) Delisted Tax (F) −155 -$5.4K EDGAR
2021-08-16 Bruker Cellular Analysis, Inc. (BLI) Delisted Mixed +200 -$289.5K EDGAR
2021-07-14 Bruker Cellular Analysis, Inc. (BLI) Delisted Mixed — -$466.4K EDGAR
2021-06-16 Bruker Cellular Analysis, Inc. (BLI) Delisted Mixed — -$595.1K EDGAR
2021-05-24 Bruker Cellular Analysis, Inc. (BLI) Delisted Mixed +4,845 -$6.5K EDGAR
2021-05-13 Bruker Cellular Analysis, Inc. (BLI) Delisted Mixed — -$577.7K EDGAR
2021-04-14 Bruker Cellular Analysis, Inc. (BLI) Delisted Mixed — -$337.1K EDGAR
2021-03-18 Bruker Cellular Analysis, Inc. (BLI) Delisted Mixed — -$398.3K EDGAR
Showing 1–10 of 56
Page 1 of 6
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.